Cargando…
Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
Altered fibrin clot structure has been reported both in patients with coronary artery disease (CAD) and those with type 2 diabetes mellitus (DM2). The aim of the present study was to evaluate plasma fibrin clot permeability and susceptibility to lysis in patients with DM2 and CAD. We studied 132 con...
Autores principales: | Bochenek, Maciej, Zalewski, Jaroslaw, Sadowski, Jerzy, Undas, Anetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549239/ https://www.ncbi.nlm.nih.gov/pubmed/23086579 http://dx.doi.org/10.1007/s11239-012-0821-8 |
Ejemplares similares
-
Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
por: Gajos, Grzegorz, et al.
Publicado: (2015) -
Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
por: Bryk, Agata Hanna, et al.
Publicado: (2021) -
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021) -
Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021) -
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)